Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul;52(2):405-406.
doi: 10.1111/apt.15837.

Editorial: the road to elimination of viral hepatitis-another promising real-world experience

Mohamed M Abdel-Daim  1   2
Affiliations
Editorial

Editorial: the road to elimination of viral hepatitis-another promising real-world experience

Mohamed M Abdel-Daim. Aliment Pharmacol Ther. 2020 Jul.
No abstract available

PubMed Disclaimer

Comment on

  • A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease.
    Dulai PS, Amiot A, Peyrin-Biroulet L, Jairath V, Serrero M, Filippi J, Singh S, Pariente B, Loftus EV Jr, Roblin X, Kane S, Buisson A, Siegel CA, Bouhnik Y, Sandborn WJ, Lasch K, Rosario M, Feagan BG, Bojic D, Trang-Poisson C, Shen B, Altwegg R, Sands BE, Colombel JF, Carbonnel F; GETAID OBSERV-IBD, VICTORY Cohorts Collaboration*. Dulai PS, et al. Aliment Pharmacol Ther. 2020 Mar;51(5):553-564. doi: 10.1111/apt.15609. Epub 2019 Dec 22. Aliment Pharmacol Ther. 2020. PMID: 31867766 Free PMC article.

References

REFERENCES

    1. World Health Organization. Global health sector strategy on viralhepatitis 2016-2021. Towards ending viral hepatitis. 2016, 56. http://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-e...
    1. Jensen D, O'Leary J, Pockros P, et al. Safety and efficacy of sofosbuvir-containing regimens for hepatitis C: real-world experience in a diverse, longitudinal observational cohort 45. Hepatology. 2014;60:45.
    1. Zoulim F, Liang TJ, Gerbes AL, et al. Hepatitis C virus treatment in the real world: optimising treatment and access to therapies. Gut. 2015;64:1824-1833.
    1. Ahmed H, Abushouk AI, Menshawy A, et al. Meta-analysis of grazoprevir plus elbasvir for treatment of hepatitis C virus genotype 1 infection. Ann Hepatol. 2018;17:18-32.
    1. Ahmed H, Abushouk AI, Menshawy A, et al. Safety and efficacy of ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin for treatment of hepatitis C virus genotype 1: a systematic review and meta-analysis. Clin Drug Invest. 2017;37:1009-1023.

LinkOut - more resources